rs2968863 — KCNH2

The QTc Modifier Near KCNH2 Linked to Early-Onset Atrial Fibrillation

The KCNH2 gene encodes Kv11.1, more commonly known as the hERG potassium channel¹¹ hERG potassium channel
Human Ether-à-go-go Related Gene; the primary channel carrying the rapid delayed-rectifier potassium current (IKr) during cardiac repolarization. IKr is essential for terminating each heartbeat — it drives the electrical return from depolarization, setting the QTc interval and determining how quickly the heart is ready for the next beat. rs2968863 sits in the intergenic region at 7q36.1, approximately 22 kilobases upstream of KCNH2, and is in high linkage disequilibrium with the well-studied nonsynonymous variant K897T (rs1805123²² rs1805123).

The Mechanism

The T allele at rs2968863 is inherited together with the KCNH2 K897T threonine allele, which subtly alters the hERG channel's biophysical properties³³ subtly alters the hERG channel's biophysical properties — specifically reducing IKr current amplitude slightly. Paradoxically, this reduced repolarizing current slightly shortens the QTc interval (by approximately 1.4 ms per allele in large GWAS), yet increases atrial fibrillation risk. The leading hypothesis is that subtle IKr reduction alters the heterogeneity of atrial repolarization — shortening some regions while creating dispersion of refractoriness — which facilitates the re-entry circuits that initiate AF, particularly in younger hearts exposed to adrenergic triggers.

The Evidence

The primary AF evidence comes from a Danish-Norwegian case-control study of 358 lone AF patients (onset before age 50) and 751 controls⁴⁴ Danish-Norwegian case-control study of 358 lone AF patients (onset before age 50) and 751 controls
Andreasen L et al. Genetic modifier of the QTc interval associated with early-onset atrial fibrillation. Can J Cardiol. 2013;29(10):1234-40. Homozygous T;T carriers had a 2.40-fold increased risk (P = 0.001, Bonferroni-corrected P = 0.016) — one of the strongest single-variant AF associations described in a young, otherwise healthy population. The association remained after excluding carriers of classical long QT mutations, confirming the effect was independent of overt channelopathy.

The QTc-shortening effect of rs2968863 was independently established in a GWAS of 15,842 Europeans across five cohorts⁵⁵ GWAS of 15,842 Europeans across five cohorts
Pfeufer A et al. Common variants at ten loci modulate the QT interval duration. Nat Genet. 2009;41(4):407-14, which identified the KCNH2 locus as one of ten reproducible QT-modulating regions. The T allele shortens QTc by approximately 1.4 ms — a modest absolute shift but biologically meaningful at the atrial level where refractoriness margins are narrower.

In an East Asian validation cohort (Juang JM et al., 2020, n=190 Taiwanese Brugada syndrome patients⁶⁶ Juang JM et al., 2020, n=190 Taiwanese Brugada syndrome patients), rs2968863 was among 22 of 88 tested SNPs that validated, and was independently associated with the composite endpoint of sudden cardiac arrest and syncope — suggesting the variant may also modulate risk of ventricular arrhythmia in the context of primary cardiac channelopathies.

Practical Actions

For T;T homozygotes, the actionable priority is early cardiovascular rhythm screening — specifically a 12-lead ECG with QTc measurement and ambulatory Holter monitoring to detect subclinical AF episodes before symptoms develop. Electrolyte balance (magnesium and potassium) is particularly important because both ions directly modulate IKr function, and even modest deficiencies can unmask latent repolarization instability in individuals with reduced hERG reserve. Stimulants and drugs known to inhibit hERG (antihistamines, some antibiotics, certain antipsychotics) carry a higher-than-average relevance for this genotype.

C;T heterozygotes carry one T allele and have a partial increase in AF susceptibility. Awareness of AF symptoms (palpitations, exercise intolerance, irregular pulse) and periodic rhythm checking is appropriate.

Interactions

rs2968863 is in high LD with KCNH2 K897T (rs1805123). The K897T variant has also been studied independently for AF risk (OR ~1.25 per allele in a two-stage European study of 1,207 cases and 2,475 controls; PMID 18222980). Together they represent the same haplotype. The NOS1AP variant rs10918594 is an independent QTc modifier at chromosome 1q23.3 — individuals who carry risk alleles at both loci have an additive QTc effect that may further increase atrial repolarization dispersion and AF susceptibility.